Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Economy & Forex

News : Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

BioNTech expects pre-reserved vaccine bottling capacity to be freed up

10/08/2020 | 07:37am EST
FILE PHOTO: The headquarters of German biotech firm BioNTech is photographed in Mainz

FRANKFURT (Reuters) - BioNTech said global capacity to bottle new COVID-19 vaccines, which is in tight supply as producers hoping to develop successful candidates book up slots, will likely be more freely available once some drop out of the race.

"If clinical trials fail or get delayed, capacity may be freed up again," Sierk Poetting, BioNTech's head of operations and finance, told an online news conference on Thursday.

"The (fill and finish) market is indeed very tight because everyone has reserved capacity, but I believe we will see some adjustments there once the first products are on the market," he said.

"This is certainly a type of capacity that can be more easily transferred (than production capacity)."

More than 40 experimental vaccines are currently being tested on volunteers around the globe to combat the new coronavirus, which has claimed more than 1 million lives.

Also speaking at the briefing, German research minister Anja Karliczek reiterated a prediction that it would likely take until mid-2021 for a vaccine to be available to the overall population, as production ramp-ups would take some time.

BioNTech and its partner Pfizer have said that if they win approval for their vaccine candidate, they aim to supply up to 100 million doses worldwide by the end of 2020 and a further 1.3 billion by the end of 2021.

(Additional reporting by Thomas Escritt; Editing by Maria Sheahan and Jan Harvey)

By Ludwig Burger


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
BIONTECH SE 6.21% 121.09 Delayed Quote.257.41%
PFIZER, INC. 3.53% 40.8 Delayed Quote.9.91%
UNITED PARCEL SERVICE 0.52% 168.83 Delayed Quote.44.23%
Latest news "Economy & Forex"
06:16aPhilippines sees deeper-than-expected economic contraction in 2020
RE
06:15aCIBC quarterly profit slumps on U.S. commercial banking weakness
RE
06:11aGaps to bridge in Brexit talks still 'substantial' - EU diplomat
RE
06:11aTESCO BOSS CALLS ON UK : give us greater post-Brexit border clarity
RE
06:10aCovid-19 Drags on Europe's Economies as Asia's Recovery Continues
DJ
06:03aEuro zone retail sales rebound more than expected in October
RE
05:57aChina will step up supervision of rental housing market - Vice Premier
RE
05:57aUK firms see brighter 2021 after vaccine news, surveys show
RE
05:57aOLIVE OIL : High Vacuum Technology increases content of phenolic compounds in extra virgin olive oil. University of Perugia and Sant'Anna School of Pisa joint research results published in journal “Food Chemistry”
PU
05:55aCMVM COMISSÃO DO MERCADO DE VALORES MOBIL : Portuguese capital markets benchmarks - November 2020
PU
Latest news "Economy & Forex"